CFIHX | TIBIX | CFIHX / TIBIX | |
Total Expense Ratio | 0.27 | 0.93 | 29% |
Annual Report Gross Expense Ratio | 0.27 | 0.93 | 29% |
Fund Existence | 8 years | 22 years | - |
Gain YTD | 10.546 | 16.359 | 64% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 2500000 | 40% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 115B | 16B | 719% |
Annual Yield % from dividends | 3.35 | 4.20 | 80% |
Returns for 1 year | 14.28 | 22.66 | 63% |
Returns for 3 years | 33.51 | 60.24 | 56% |
Returns for 5 years | 50.24 | 96.20 | 52% |
Returns for 10 years | N/A | 99.28 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
TMV | 39.58 | 1.15 | +2.99% |
Direxion Daily 20+ Yr Trsy Bear 3X ETF | |||
IBMO | 25.57 | 0.02 | +0.06% |
iShares iBonds Dec 2026 Term Muni Bd ETF | |||
CNCR | 9.02 | N/A | N/A |
Range Cancer Therapeutics ETF | |||
SPXN | 64.56 | N/A | N/A |
ProShares S&P 500® ex-Financials | |||
UITB | 46.45 | -0.14 | -0.30% |
VictoryShares Core Intermediate Bond ETF |